Search

everythinglearnresearchcommunity

for

Search:↓

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Finasteride effectively reduces prostate size and symptoms in most BPH patients.

PSA levels help determine prostate size and guide treatment choices for benign prostatic hyperplasia.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

GABA contributes to stress-related hair loss, and ginkgolide A may help treat it.

Early hormones shape sex-specific differences in rat glands.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Many drugs, not just chemotherapy, can cause reversible hair loss.

Roota Hair Growth promotes fuller, healthier hair using plant-based ingredients and requires consistent use.

Roota Hair Growth promotes fuller, healthier hair using plant-based ingredients.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Combining α-blockers and Finasteride is useful for treating small prostate enlargement.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.